Satellos Bioscience MSLE
NASDAQ MSLE
$8.51 +0.03 (+0.41%)
As of: Oct 1, 2026 · 3:51 PM EDT

Satellos Bioscience (MSLE) Accumulated Expenses (2025 - 2026)

Updated

Satellos Bioscience's Accumulated Expenses came in at $4.16 million for the quarter ended Jun 30, 2026.

Analysis

Satellos Bioscience (MSLE) Accumulated Expenses (2025 - 2026) Analysis & Trends

As of Dec 31, 2025, Satellos Bioscience's Accumulated Expenses was $2.26 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Satellos Bioscience 131.40 Mn 131.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.16 Mn
Dec 31, 2025 2.26 Mn
API Access

Satellos Bioscience Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MSLE&period=max&api_key=YOUR_API_KEY